Sign Up to like & get
recommendations!
0
Published in 2024 at "Cell Biochemistry and Function"
DOI: 10.1002/cbf.4075
Abstract: The interaction between murine double minute 2 (MDM2) and p53, marked by transcriptional induction and feedback inhibition, orchestrates a functional loop dictating cellular fate. The functional loop comprising p53‐MDM2 axis is made up of an…
read more here.
Keywords:
mdm2 axis;
p53 mdm2;
p53;
mdm2 interactome ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Cancer letters"
DOI: 10.1016/j.canlet.2020.09.023
Abstract: Despite being the subject of extensive research and clinical trials, neuroblastoma remains a major therapeutic challenge in pediatric oncology. The p53 protein is a central safeguard that protects cells against genome instability and malignant transformation.…
read more here.
Keywords:
p53;
p53 mdm2;
mdm2 pathway;
pathway neuroblastoma ... See more keywords
Photo from archive.org
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Molecular Structure"
DOI: 10.1016/j.molstruc.2019.127252
Abstract: Abstract Novel heterocyclic bioactive small molecules bearing thioether moiety, fluorine containing dihydro pyridine and dihydro pyran were synthesized and characterized using spectroscopic methods (FT-IR, 1H, 13C and 19F NMR), LC-MS and SC-XRD. The reaction conducted…
read more here.
Keywords:
tpgs mediated;
mediated one;
one pot;
p53 mdm2 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of chemical information and modeling"
DOI: 10.1021/acs.jcim.9b00920
Abstract: Intrinsically disordered proteins (IDPs) exert their functions by binding to partner proteins via a complex process that includes coupled folding and binding. Motivated by that inhibiting the binding of the IDP p53 to its partner…
read more here.
Keywords:
folding binding;
coupled folding;
process;
p53 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.4c00784
Abstract: While a number of p53-MDM2 inhibitors have progressed into clinical trials for the treatment of cancer, their progression has been hampered by a variety of problems, including acquired drug resistance, dose-dependent toxicity, and limited clinical…
read more here.
Keywords:
antitumor agents;
p53 mdm2;
p53;
mdm2 inhibitor ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.5c01003
Abstract: The blocking interaction between p53 and its negative regulator MDM2 is an engaging therapeutic strategy for antitumor drug development, and there are several drug candidates of p53-MDM2 inhibitors in clinical trials. In the present study,…
read more here.
Keywords:
novel drug;
treatment;
p53 mdm2;
drug ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of Medicinal Chemistry"
DOI: 10.1021/acs.jmedchem.9b00993
Abstract: The use of peptidomimetic scaffolds is a promising strategy for the inhibition of protein–protein interactions (PPIs). Herein, we demonstrate that sulfono-γ-AApeptides can be rationally designed to mimic the p53 α-helix and inhibit p53–MDM2 PPIs. The…
read more here.
Keywords:
protein;
protein interactions;
protein protein;
sulfono aapeptides ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2021 at "ACS chemical biology"
DOI: 10.1021/acschembio.0c00988
Abstract: Peptides are being developed as targeted anticancer drugs to modulate cytosolic protein-protein interactions involved in cancer progression. However, their use as therapeutics is often limited by their low cell membrane permeation and/or inability to reach…
read more here.
Keywords:
cancer;
cell;
p53 mdm2;
angler peptides ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "ACS Omega"
DOI: 10.1021/acsomega.9b03459
Abstract: The Sondheimer dialkyne reagent has previously been employed in strain-promoted double-click cycloadditions with bis-azide peptides to generate stapled peptide inhibitors of protein-protein interactions. The substituted variants of the Sondheimer dialkyne can be used to generate…
read more here.
Keywords:
sondheimer dialkyne;
strain promoted;
stapled peptide;
p53 mdm2 ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
1
Published in 2018 at "Cell Death and Differentiation"
DOI: 10.1038/cdd.2017.187
Abstract: In response to varying stress signals, the p53 tumor suppressor is able to promote repair, survival, or elimination of damaged cells – processes that have great relevance to organismal aging. Although the link between p53…
read more here.
Keywords:
p53;
p53 mdm2;
mdm2 axis;
relevance p53 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-025-10589-8
Abstract: Cancer cells have a higher evolutionary potential than normal cells, which commonly leads to medication resistance and a decrease in the efficacy of existing cancer treatments. As a result, discovering new therapeutic drugs is an…
read more here.
Keywords:
p53 mdm2;
mdm2;
asinex database;
p53 ... See more keywords